New tool aims to boost lung cancer trial enrollment

NCT ID NCT05888584

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study aims to develop and test a tool that helps lung cancer nurses talk to patients about clinical trials. Only about 8% of lung cancer patients in the UK join trials, and nurses often lack the time or confidence to discuss them. The tool will be tested in four UK hospitals to see if it improves the number and quality of these conversations.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Research readiness tool
What this could lead to
If effective, this tool could help more lung cancer patients learn about and join clinical trials, potentially improving their treatment options and outcomes.
What could go wrong
This is an early-stage study testing a tool in a small number of hospitals. It may not work in other settings or significantly change recruitment rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Derby and Burton NHS

    Derby, Derbyshire, United Kingdom

  • Lanarkshire NHS

    Glasgow, United Kingdom

  • Oxford University Hospitals

    Oxford, Oxfordshire, United Kingdom

  • Royal Surrey County Hospital

    Guildford, Surrey, United Kingdom

  • Sheffield Teaching Hospitals NHS

    Sheffield, Yorkshire, United Kingdom

  • Sherwood Forest NHS

    Nottingham, Nottinghamshire, United Kingdom

  • St Bartholomews Hospital NHS

    London, Greater London, United Kingdom

  • The Christie NHS

    Manchester, Greater Manchester, United Kingdom

  • The Royal Marsden NHS

    London, Greater London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.